Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

The document concludes that dermal papilla cells are key for hair growth and could be used in new hair loss treatments.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Using neurohormones to control keratin can lead to new skin disease treatments.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

The cause of atypical Cushing's syndrome in dogs, possibly linked to sex hormones, is not yet proven.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Vesicular carriers like liposomes may improve cosmetic skin treatment delivery and effectiveness but need more human research.

Looking at skin can help find and treat serious diseases early.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

Apoptosis contributes to hair loss in androgenetic alopecia.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.